At NGM, we pride ourselves on conducting world-class science and sharing our research efforts with the broader scientific and medical communities.
Feb 24, 2025
NGM Bio Announces First Participant Dosed in EMERALD Phase 2 Clinical Study of NGM120 for the Treatment of Hyperemesis Gravidarum (HG) in Pregnant Patients
